Search research articles
Contact Us
Filters
Showing results (191-200 of 520) with videos related to
Page
of 52
Sort By:
The American Journal of Cardiology
|
June 29, 2004
Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)
Satish Kenchaiah, Marc A Pfeffer, Martin St John Sutton, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 22, 2008
Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial
Andrew G Bostom, Myra A Carpenter, Lawrence Hunsicker, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
February 7, 2012
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction
Alessandra Meris, Maria Amigoni, Anil Verma, et al.
European Heart Journal
|
October 13, 2005
Predictors of mortality and morbidity in patients with chronic heart failure
Stuart J Pocock, Duolao Wang, Marc A Pfeffer, et al.
Diabetes Research and Clinical Practice
|
November 21, 2022
Importance of NT-proBNP and conventional risk factors for prediction of death in older adults with and without diabetes mellitus- A report from the Atherosclerosis Risk in Communities (ARIC) study
Magnus O Wijkman, Brian L Claggett, Marcus V B Malachias, et al.
European Journal of Heart Failure
|
September 19, 2018
The frailty syndrome and outcomes in the TOPCAT trial
Natalie A Sanders, Mark A Supiano, Eldrin F Lewis, et al.
European Journal of Heart Failure
|
February 5, 2008
Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial
R A P Weir, John J V McMurray, Margareta Puu, et al.
The New England Journal of Medicine
|
March 10, 2004
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
Christopher P Cannon, Eugene Braunwald, Carolyn H McCabe, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
December 2, 2006
Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study
Jens Jakob Thune, Lars Køber, Marc A Pfeffer, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 13, 2009
Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome
Lisa M Mielniczuk, Marc A Pfeffer, Eldrin F Lewis, et al.
Page
of 52
Search research articles
Search
Showing results (191-200 of 520) with videos related to
Sort By:
Page
of 52
The American Journal of Cardiology
|
June 29, 2004
Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)
Satish Kenchaiah, Marc A Pfeffer, Martin St John Sutton, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 22, 2008
Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial
Andrew G Bostom, Myra A Carpenter, Lawrence Hunsicker, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
February 7, 2012
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction
Alessandra Meris, Maria Amigoni, Anil Verma, et al.
European Heart Journal
|
October 13, 2005
Predictors of mortality and morbidity in patients with chronic heart failure
Stuart J Pocock, Duolao Wang, Marc A Pfeffer, et al.
Diabetes Research and Clinical Practice
|
November 21, 2022
Importance of NT-proBNP and conventional risk factors for prediction of death in older adults with and without diabetes mellitus- A report from the Atherosclerosis Risk in Communities (ARIC) study
Magnus O Wijkman, Brian L Claggett, Marcus V B Malachias, et al.
European Journal of Heart Failure
|
September 19, 2018
The frailty syndrome and outcomes in the TOPCAT trial
Natalie A Sanders, Mark A Supiano, Eldrin F Lewis, et al.
European Journal of Heart Failure
|
February 5, 2008
Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial
R A P Weir, John J V McMurray, Margareta Puu, et al.
The New England Journal of Medicine
|
March 10, 2004
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
Christopher P Cannon, Eugene Braunwald, Carolyn H McCabe, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
December 2, 2006
Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study
Jens Jakob Thune, Lars Køber, Marc A Pfeffer, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 13, 2009
Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome
Lisa M Mielniczuk, Marc A Pfeffer, Eldrin F Lewis, et al.
Page
of 52